Abstract
The pathogenesis of Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas (OAEMZLs) is poorly understood. OAEMZLs are monoclonal tumors expressing a biased repertoire of mutated surface immunoglobulins. Antigenic activation of the B-cell receptor (BCR) may have a role in the pathogenesis of these lymphomas. We have analyzed the reactivity of recombinant OAEMZL immunoglobulins. OAEMZL antibodies reacted with self-human antigens, as demonstrated by enzyme-linked immunosorbent assays, HEp-2 immunofluorescence and human protein microarrays. All the analyzed recombinant antibodies (rAbs) exhibited polyreactivity by comprehensive protein array antibody reactivity and some rAbs also demonstrated rheumatoid factor activity. The identity of several reactive antigens was confirmed by microcapillary reverse-phase high-performance liquid chromatography nano-electrospray tandem mass spectrometry. The tested rAbs frequently reacted with shared intracellular and extracellular self-antigens (for example, galectin-3). Furthermore, these self-antigens induced BCR signaling in B cells expressing cognate surface immunoglobulins derived from OAEMZLs. These findings indicate that interactions between self-antigens and cognate OAEMZL tumor-derived BCRs are functional, inducing intracellular signaling. Overall, our findings suggest that self-antigen-induced BCR stimulation may be implicated in the pathogenesis of C. psittaci-negative OAEMZLs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
Stefanovic A, Lossos IS . Extranodal marginal zone lymphoma of the ocular adnexa. Blood 2009; 114: 501–510.
Isaacson PG, Du MQ . MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004; 4: 644–653.
Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG . Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175–1176.
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239–248.
Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000; 31: 263–268.
Hyjek E, Isaacson PG . Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol 1988; 19: 1315–1326.
Hyjek E, Smith WJ, Isaacson PG . Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol 1988; 19: 766–776.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn, vol. 2. World Health Organization: Geneva, Switzerland, 2008.
Streubel B, Simonitsch-Klupp I, Mullauer L, Lamprecht A, Huber D, Siebert R et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia 2004; 18: 1722–1726.
Zhu D, Ikpatt OF, Dubovy SR, Lossos C, Natkunam Y, Chapman-Fredricks JR et al. Molecular and genomic aberrations in Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. Am J Hematol 2013; 88: 730–735.
Zhu D, Lossos C, Chapman-Fredricks JR, Matthews JM, Ikpatt OF, Ruiz P et al. Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas. PloS One 2011; 6: e29114.
Zhu D, Lossos C, Chapman-Fredricks JR, Lossos IS . Biased immunoglobulin light chain use in the Chlamydophila psittaci negative ocular adnexal marginal zone lymphomas. Am J Hematol 2013; 88: 379–384.
Rosado MF, Byrne Jr GE, Ding F, Fields KA, Ruiz P, Dubovy SR et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006; 107: 467–472.
Decaudin D, Dolcetti R, de Cremoux P, Ponzoni M, Vincent-Salomon A, Doglioni C et al. Variable association between Chlamydophila psittaci infection and ocular adnexal lymphomas: methodological biases or true geographical variations? Anticancer Drugs 2008; 19: 761–765.
Ruiz A, Reischl U, Swerdlow SH, Hartke M, Streubel B, Procop G et al. Extranodal marginal zone B-cell lymphomas of the ocular adnexa: multiparameter analysis of 34 cases including interphase molecular cytogenetics and PCR for Chlamydia psittaci. Am J Surg Pathol 2007; 31: 792–802.
Zhang GS, Winter JN, Variakojis D, Reich S, Lissner GS, Bryar P et al. Lack of an association between Chlamydia psittaci and ocular adnexal lymphoma. Leuk Lymphoma 2007; 48: 577–583.
Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 2010; 463: 88–92.
Sachen KL, Strohman MJ, Singletary J, Alizadeh AA, Kattah NH, Lossos C et al. Self-antigen recognition by follicular lymphoma B-cell receptors. Blood 2012; 120: 4182–4190.
Cha SC, Qin H, Kannan S, Rawal S, Watkins LS, Baio FE et al. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J Immunol 2013; 190: 4887–4898.
Duhren-von Minden M, Ubelhart R, Schneider D, Wossning T, Bach MP, Buchner M et al. Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling. Nature 2012; 489: 309–312.
Craig VJ, Arnold I, Gerke C, Huynh MQ, Wundisch T, Neubauer A et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 2010; 115: 581–591.
Bende RJ, Aarts WM, Riedl RG, de Jong D, Pals ST, van Noesel CJ . Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005; 201: 1229–1241.
Stevenson FK, Smith GJ, North J, Hamblin TJ, Glennie MJ . Identification of normal B-cell counterparts of neoplastic cells which secrete cold agglutinins of anti-I and anti-i specificity. Br J Haematol 1989; 72: 9–15.
Thorpe SJ, Ball C, Fox B, Thompson KM, Thorpe R, Bristow A . Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivities. Transfusion 2008; 48: 930–940.
Warsame AA, Aasheim HC, Nustad K, Troen G, Tierens A, Wang V et al. Splenic marginal zone lymphoma with VH1-02 gene rearrangement expresses poly- and self-reactive antibodies with similar reactivity. Blood 2011; 118: 3331–3339.
Lu X, Chen J, Sasmono RT, Hsi ED, Sarosiek KA, Tiganis T et al. T-cell protein tyrosine phosphatase, distinctively expressed in activated-B-cell-like diffuse large B-cell lymphomas, is the nuclear phosphatase of STAT6. Mol Cell Biol 2007; 27: 2166–2179.
Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA et al. Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol 2009; 22: 1312–1320.
Romero-Camarero I, Jiang X, Natkunam Y, Lu X, Vicente-Duenas C, Gonzalez-Herrero I et al. Germinal centre protein HGAL promotes lymphoid hyperplasia and amyloidosis via BCR-mediated Syk activation. Nat Commun 2013; 4: 1338.
Newlaczyl AU, Yu LG . Galectin-3—a jack-of-all-trades in cancer. Cancer Lett 2011; 313: 123–128.
Song L, Tang JW, Owusu L, Sun MZ, Wu J, Zhang J . Galectin-3 in cancer. Clin Chim Acta 2014; 431: 185–191.
Hoyer KK, Pang M, Gui D, Shintaku IP, Kuwabara I, Liu FT et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 2004; 164: 893–902.
Sarter K, Janko C, Andre S, Munoz LE, Schorn C, Winkler S et al. Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus. Glycobiology 2013; 23: 12–22.
Suarez-Alvarez B, Garcia Suarez MM, Arguelles ME, Sampedro A, Alvarez Marcos C, Mira E et al. Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma. Anticancer Res 2001; 21: 3677–3684.
Chen L, Monti S, Juszczynski P, Daley J, Chen W, Witzig TE et al. SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma. Blood 2008; 111: 2230–2237.
Catera R, Silverman GJ, Hatzi K, Seiler T, Didier S, Zhang L et al. Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med 2008; 14: 665–674.
Chu CC, Catera R, Zhang L, Didier S, Agagnina BM, Damle RN et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 2010; 115: 3907–3915.
Seiler T, Woelfle M, Yancopoulos S, Catera R, Li W, Hatzi K et al. Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells. Blood 2009; 114: 3615–3624.
Niemann CU, Wiestner A . B-cell receptor signaling as a driver of lymphoma development and evolution. Semin Cancer Biol 2013; 23: 410–421.
Wang ML, Rule S, Martin P, Goy A, Auer R, Kahl BS et al. Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 2013; 369: 507–516.
Byrd JC, Furman RR, Coutre SE, Flinn IW, Burger JA, Blum KA et al. Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med 2013; 369: 32–42.
Mouquet H, Scheid JF, Zoller MJ, Krogsgaard M, Ott RG, Shukair S et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature 2010; 467: 591–595.
Cyster JG . B cell follicles and antigen encounters of the third kind. Nat Immunol 2010; 11: 989–996.
Novak R, Dabelic S, Dumic J . Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages. Biochim Biophys Acta 2012; 1820: 1383–1390.
Dimitrov JD, Planchais C, Roumenina LT, Vassilev TL, Kaveri SV, Lacroix-Desmazes S . Antibody polyreactivity in health and disease: statu variabilis. J Immunol 2013; 191: 993–999.
Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC . Predominant autoantibody production by early human B cell precursors. Science 2003; 301: 1374–1377.
Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H . Autoreactivity in human IgG+ memory B cells. Immunity 2007; 26: 205–213.
Acknowledgements
ISL is supported by National Institutes of Health (NIH) grant NIH CA109335, the Lymphoma Research Foundation and the Dwoskin Family, Recio Family, Greg Olsen and Anthony Rizzo Family Foundations.
Author Contributions
DZ and SB performed most of the laboratory work, analyzed the data and wrote the manuscript; XL and FG performed the laboratory experiments; HV analyzed the data; DKH and F-TL provided the reagents and useful discussion; and SAC, KK and FV performed the double immunofluorescence experiments. JRC-F performed the laboratory experiments and analyzed the data; ISL conceptualized the idea of the study, supervised the experiments, analyzed the data and wrote the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Zhu, D., Bhatt, S., Lu, X. et al. Chlamydophila psittaci-negative ocular adnexal marginal zone lymphomas express self polyreactive B-cell receptors. Leukemia 29, 1587–1599 (2015). https://doi.org/10.1038/leu.2015.39
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2015.39